Literature DB >> 26464204

Comparative Genomics of Community-Associated Methicillin-Resistant Staphylococcus aureus Shows the Emergence of Clone ST8-USA300 in Geneva, Switzerland.

Elodie Von Dach1, Seydina M Diene2, Carolina Fankhauser1, Jacques Schrenzel2, Stephan Harbarth1, Patrice François2.   

Abstract

BACKGROUND: Previous investigations of community-associated methicillin-resistant Staphylococcus aureus(CA-MRSA) isolates have revealed a wide diversity of genetic backgrounds, with only sporadic occurrence of ST8-USA300, in Geneva, Switzerland. We conducted a molecular epidemiologic analysis to identify the origin of a sudden increase of ST8 PVL-positive isolates in Geneva during 2013.
METHODS: On the basis of prospective CA-MRSA surveillance, we collected colonizing and infecting ST8-USA300 isolates and compared them to non-ST8 CA-MRSA isolates. Whole-genome sequencing (WGS) was performed for each isolate of this collection, and discriminating molecular features were linked to patient data.
RESULTS: In 2013, 22 isolates with the ST8-USA300 profile were identified among 46 cases of CA-MRSA. WGS revealed 2 groups of strains that differed by the type of the SCCmec IV element encoded and whether they harbored an arginine catabolism mobile element (ACME) locus. ACME-negative strains were mainly isolated from patients traveling in or originating from South America. Single-nucleotide polymorphism positions in isolate groups were used to infer their common ancestor, determine their geographical origin, and trace their relatedness.
CONCLUSIONS: WGS allowed the identification of transmission events and revealed that the increased prevalence of USA300 CA-MRSA isolates resulted from multiple importation events from the Americas but not from local clonal expansion of a successful clone.
© The Author 2015. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup.com.

Entities:  

Keywords:  USA300; comparative genomics; epidemiological survey; genome evolution; high throughput sequencing; importation event; methicillin-resistant Staphylococcus aureus

Mesh:

Substances:

Year:  2015        PMID: 26464204     DOI: 10.1093/infdis/jiv489

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  18 in total

1.  Global Spread of the Community-Associated Methicillin-Resistant Staphylococcus aureus USA300 Latin American Variant.

Authors:  Paul J Planet; Lorena Diaz; Rafael Rios; Cesar A Arias
Journal:  J Infect Dis       Date:  2016-09-09       Impact factor: 5.226

Review 2.  Life After USA300: The Rise and Fall of a Superbug.

Authors:  Paul J Planet
Journal:  J Infect Dis       Date:  2017-02-15       Impact factor: 5.226

3.  An outbreak in intravenous drug users due to USA300 Latin-American variant community-acquired methicillin-resistant Staphylococcus aureus in France as early as 2007.

Authors:  M Sassi; B Felden; M Revest; P Tattevin; Y Augagneur; P-Y Donnio
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-09-02       Impact factor: 3.267

4.  Antimicrobial activity of ceftaroline against methicillin-resistant Staphylococcus aureus (MRSA) isolates collected in 2013-2014 at the Geneva University Hospitals.

Authors:  D O Andrey; P François; C Manzano; E J Bonetti; S Harbarth; J Schrenzel; W L Kelley; A Renzoni
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-10-15       Impact factor: 3.267

5.  Management and investigation of a Serratia marcescens outbreak in a neonatal unit in Switzerland - the role of hand hygiene and whole genome sequencing.

Authors:  Walter Zingg; Isabelle Soulake; Damien Baud; Benedikt Huttner; Riccardo Pfister; Gesuele Renzi; Didier Pittet; Jacques Schrenzel; Patrice Francois
Journal:  Antimicrob Resist Infect Control       Date:  2017-12-11       Impact factor: 4.887

6.  Range Expansion and the Origin of USA300 North American Epidemic Methicillin-Resistant Staphylococcus aureus.

Authors:  Lavanya Challagundla; Xiao Luo; Isabella A Tickler; Xavier Didelot; David C Coleman; Anna C Shore; Geoffrey W Coombs; Daniel O Sordelli; Eric L Brown; Robert Skov; Anders Rhod Larsen; Jinnethe Reyes; Iraida E Robledo; Guillermo J Vazquez; Raul Rivera; Paul D Fey; Kurt Stevenson; Shu-Hua Wang; Barry N Kreiswirth; Jose R Mediavilla; Cesar A Arias; Paul J Planet; Rathel L Nolan; Fred C Tenover; Richard V Goering; D Ashley Robinson
Journal:  mBio       Date:  2018-01-02       Impact factor: 7.867

7.  Complete Genome Sequence of a Community-Associated Methicillin-Resistant Staphylococcus aureus Hypervirulent Strain, USA300-C2406, Isolated from a Patient with a Lethal Case of Necrotizing Pneumonia.

Authors:  Jo-Ann McClure; Kunyan Zhang
Journal:  Genome Announc       Date:  2017-06-01

8.  Demography and Intercontinental Spread of the USA300 Community-Acquired Methicillin-Resistant Staphylococcus aureus Lineage.

Authors:  Philippe Glaser; Patrícia Martins-Simões; Adrien Villain; Maxime Barbier; Anne Tristan; Christiane Bouchier; Laurence Ma; Michele Bes; Frederic Laurent; Didier Guillemot; Thierry Wirth; François Vandenesch
Journal:  MBio       Date:  2016-02-16       Impact factor: 7.867

9.  Systematic Surveillance Detects Multiple Silent Introductions and Household Transmission of Methicillin-Resistant Staphylococcus aureus USA300 in the East of England.

Authors:  Michelle S Toleman; Sandra Reuter; Francesc Coll; Ewan M Harrison; Beth Blane; Nicholas M Brown; M Estée Török; Julian Parkhill; Sharon J Peacock
Journal:  J Infect Dis       Date:  2016-04-27       Impact factor: 5.226

10.  Origin, evolution, and global transmission of community-acquired Staphylococcus aureus ST8.

Authors:  Lena Strauß; Marc Stegger; Patrick Eberechi Akpaka; Abraham Alabi; Sebastien Breurec; Geoffrey Coombs; Beverly Egyir; Anders Rhod Larsen; Frederic Laurent; Stefan Monecke; Georg Peters; Robert Skov; Birgit Strommenger; François Vandenesch; Frieder Schaumburg; Alexander Mellmann
Journal:  Proc Natl Acad Sci U S A       Date:  2017-11-20       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.